| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 131.35 mm | 131.35 mm | 131.35 mm | 131.35 mm | 131.35 mm | 131.35 mm |
| Cash burn (monthly) | 74.84 mm | 8.28 mm | 13.82 mm | (no burn) | 9.29 mm | (no burn) |
| Cash used (since last report) | 301.03 mm | 33.32 mm | 55.58 mm | n/a | 37.36 mm | n/a |
| Cash remaining | -169.68 mm | 98.03 mm | 75.77 mm | n/a | 93.99 mm | n/a |
| Runway (months of cash) | -2.3 | 11.8 | 5.5 | n/a | 10.1 | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 241 |
| Opened positions | 76 |
| Closed positions | 26 |
| Increased positions | 77 |
| Reduced positions | 64 |
| 13F shares | Current |
|---|---|
| Total value | 2.68 tn |
| Total shares | 71.81 mm |
| Total puts | 113.80 k |
| Total calls | 76.30 k |
| Total put/call ratio | 1.5 |
| Largest owners | Shares | Value |
|---|---|---|
| BlackRock | 10.22 mm | $460.09 bn |
| Farallon Capital Management | 5.86 mm | $263.75 bn |
| Farallon Capital Partners | 5.60 mm | $143.43 mm |
| RTW Investments | 5.43 mm | $244.18 bn |
| Vanguard | 4.22 mm | $189.72 bn |
| STT State Street | 3.18 mm | $143.26 bn |
| Biotechnology Value Fund L P | 2.97 mm | $141.45 mm |
| JNJ Johnson & Johnson | 2.45 mm | $110.21 bn |
| BVF | 1.85 mm | $83.26 bn |
| JEF Jefferies Financial | 1.81 mm | $81.66 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Jan 25 | Asif Ali | Common Stock | Sell | Dispose S | No | No | 0 | 2,601 | 0.00 | 62,821 |
| 16 Jan 25 | Asif Ali | Common Stock | Sell | Dispose S | No | No | 0 | 1,317 | 0.00 | 65,422 |
| 16 Jan 25 | Molina Arturo MD | Common Stock | Sell | Dispose S | No | No | 0 | 3,252 | 0.00 | 83,892 |
| 16 Jan 25 | Molina Arturo MD | Common Stock | Sell | Dispose S | No | No | 0 | 388 | 0.00 | 87,144 |
| 15 Jan 25 | Dinesh V PH D Patel | Common Stock | Payment of exercise | Dispose F | No | No | 0 | 12,636 | 0.00 | 545,619 |
| 2 Jan 25 | Asif Ali | Common Stock | Grant | Acquire A | No | No | 0 | 31,779 | 0.00 | 66,739 |
| 2 Jan 25 | Asif Ali | Stock Option Common Stock | Grant | Acquire A | No | No | 38.98 | 38,520 | 1.50 mm | 38,520 |
| 2 Jan 25 | Molina Arturo MD | Common Stock | Grant | Acquire A | No | No | 0 | 41,088 | 0.00 | 87,532 |
| 2 Jan 25 | Molina Arturo MD | Stock Option Common Stock | Grant | Acquire A | No | No | 38.98 | 49,862 | 1.94 mm | 49,862 |
